Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Zai Lab Limited ADR shares valued at $270,678 were purchased by Amado Rafael on Apr 02 ’25. At $35.89 per share, Amado Rafael acquired 7,541 shares.
Also, Smiley Joshua L purchased 11,740 shares, netting a total of over 421,398 in proceeds.
Before that, Du Ying had added 5,808 shares to its account. In a trade valued at $208,474, the Officer bought Zai Lab Limited ADR shares for $35.89 each.
As published in their initiating research note from Scotiabank on March 07, 2025, Zai Lab Limited ADR [ZLAB] has been a Sector outperform and the price target has been revised to $55. Analysts at BofA Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early March. As of December 14, 2023, Morgan Stanley has initiated its “an Overweight” rating for ZLAB. Earlier on August 10, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for ZLAB stock.
Analyzing ZLAB Stock Performance
During the last five days, there has been a surge of approximately 7.43%. Over the course of the year, Zai Lab Limited ADR shares have jumped approximately 39.10%. Shares of the company reached a 52-week high of $39.77 on 03/28/25 and a 52-week low of $23.82 on 01/15/25. A 50-day SMA is recorded $32.34, while a 200-day SMA reached $25.44.
Support And Resistance Levels for Zai Lab Limited ADR (ZLAB)
According to the 24-hour chart, there is a support level at 35.67, which, if violated, would cause prices to drop to 34.92. In the upper region, resistance lies at 36.83. The next price resistance is at 37.24. RSI (Relative Strength Index) is 54.88 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.04, which suggests the price will decrease in the coming days. Percent R is at 51.86%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
